The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
1LIFE HEALTHCARE INC | COM | 68269G107 | 7,264 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ABBVIE INC | COM | 00287Y109 | 151,727 | 1,545,400 | SH | SOLE | 1,545,400 | 0 | 0 | ||
ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 00653A107 | 14,394 | 1,438,000 | SH | SOLE | 1,438,000 | 0 | 0 | ||
AKOUOS INC | COM | 00973J101 | 7,088 | 315,000 | SH | SOLE | 315,000 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 16,776 | 686,400 | SH | SOLE | 686,400 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 56,984 | 507,700 | SH | SOLE | 507,700 | 0 | 0 | ||
ANIKA THERAPEUTICS INC | COM | 035255108 | 13,677 | 362,490 | SH | SOLE | 362,490 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 14,572 | 589,000 | SH | SOLE | 589,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 36,119 | 1,076,900 | SH | SOLE | 1,076,900 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 17,585 | 118,900 | SH | SOLE | 118,900 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 17,242 | 325,990 | SH | SOLE | 325,990 | 0 | 0 | ||
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 40,212 | 2,474,599 | SH | SOLE | 2,474,599 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 3,700 | 457,951 | SH | SOLE | 457,951 | 0 | 0 | ||
AVANTOR INC | COM | 05352A100 | 27,404 | 1,612,000 | SH | SOLE | 1,612,000 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 6,636 | 234,814 | SH | SOLE | 234,814 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 33,315 | 404,900 | SH | SOLE | 404,900 | 0 | 0 | ||
BAXTER INTL INC | COM | 071813109 | 68,957 | 800,900 | SH | SOLE | 800,900 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 80,750 | 1,104,500 | SH | SOLE | 1,104,500 | 0 | 0 | ||
BIOXCEL THERAPEUTICS INC | COM | 09075P105 | 20,573 | 388,095 | SH | SOLE | 388,095 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | RIGHT 99/99/9999 | 110122157 | 20,717 | 5,786,941 | SH | SOLE | 5,786,941 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 37,159 | 645,800 | SH | SOLE | 645,800 | 0 | 0 | ||
COHERUS BIOSCIENCES INC | COM | 19249H103 | 18,280 | 1,023,500 | SH | SOLE | 1,023,500 | 0 | 0 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 20,158 | 274,300 | SH | SOLE | 274,300 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 9,332 | 156,266 | SH | SOLE | 156,266 | 0 | 0 | ||
DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 23,720 | 2,674,154 | SH | SOLE | 2,674,154 | 0 | 0 | ||
EDITAS MEDICINE INC | COM | 28106W103 | 17,748 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 28,718 | 559,700 | SH | SOLE | 559,700 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 63,957 | 2,694,070 | SH | SOLE | 2,694,070 | 0 | 0 | ||
FUSION PHARMACEUTICALS INC | COM | 36118A100 | 2,875 | 164,554 | SH | SOLE | 164,554 | 0 | 0 | ||
HARPOON THERAPEUTICS INC | COM | 41358P106 | 20,025 | 1,206,351 | SH | SOLE | 1,206,351 | 0 | 0 | ||
HOLOGIC INC | COM | 436440101 | 46,580 | 817,200 | SH | SOLE | 817,200 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB LTD | SHS | G46188101 | 29,802 | 536,200 | SH | SOLE | 536,200 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 18,915 | 1,331,100 | SH | SOLE | 1,331,100 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 67,736 | 1,911,300 | SH | SOLE | 1,911,300 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 8,790 | 418,178 | SH | SOLE | 418,178 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 20,273 | 738,547 | SH | SOLE | 738,547 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 32,905 | 6,426,700 | SH | SOLE | 6,426,700 | 0 | 0 | ||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 4,256 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 19,638 | 128,000 | SH | SOLE | 128,000 | 0 | 0 | ||
MEDTRONIC PLC | SHS | G5960L103 | 15,928 | 173,700 | SH | SOLE | 173,700 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 25,029 | 1,069,600 | SH | SOLE | 1,069,600 | 0 | 0 | ||
MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 38,261 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 22,582 | 185,100 | SH | SOLE | 185,100 | 0 | 0 | ||
PREVAIL THERAPEUTICS INC | COM | 74140Y101 | 15,329 | 1,028,800 | SH | SOLE | 1,028,800 | 0 | 0 | ||
PRINCIPIA BIOPHARMA INC | COM | 74257L108 | 32,795 | 548,500 | SH | SOLE | 548,500 | 0 | 0 | ||
PROGENITY INC | COM | 74319F107 | 2,148 | 238,680 | SH | SOLE | 238,680 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 82,384 | 132,100 | SH | SOLE | 132,100 | 0 | 0 | ||
RETROPHIN INC | COM | 761299106 | 5,103 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ROYALTY PHARMA PLC | SHS CL A | G7709Q104 | 9,710 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SEATTLE GENETICS INC | COM | 812578102 | 42,633 | 250,900 | SH | SOLE | 250,900 | 0 | 0 | ||
SURFACE ONCOLOGY INC | COM | 86877M209 | 9,700 | 1,478,699 | SH | SOLE | 1,478,699 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 22,636 | 1,527,400 | SH | SOLE | 1,527,400 | 0 | 0 | ||
SYNEOS HEALTH INC | CL A | 87166B102 | 21,349 | 366,500 | SH | SOLE | 366,500 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 7,594 | 4,414,991 | SH | SOLE | 4,414,991 | 0 | 0 | ||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 25,426 | 620,600 | SH | SOLE | 620,600 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 32,389 | 674,487 | SH | SOLE | 674,487 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 2,643 | 97,870 | SH | SOLE | 97,870 | 0 | 0 |